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THE EFFECTS OF CYCLIC STRAIN ON RAT TAIL TENOCYTES 
Richard Crockett, Michael Centrella, Thomas McCarthy, J. Grant Thomson.  Section of 
Plastic Surgery, Department of Surgery, Yale University, School of Medicine, New 
Haven, CT. 
 
 The purpose of this study was to examine the effects of cyclic tension on the 
expression of hyaluronic acid, its receptor (CD44), and total glycosaminoglycan content 
in tendon fibroblasts.  An in vitro model was used to analyze tenocytes from the tail 
tendons of rats.  Tenocytes in the experimental group were exposed to cyclic mechanical 
stress, and using ELISA, western blot, and colormetric dye-binding assays, the effect of 
strain on cultured tenocytes was examined. 
Tenocytes exposed to mechanical strain produced 1528 ± 58 ng/mL (mean ± 
SEM) of hyaluronic acid, while those in a control environment produced only 730 ± 27 
ng/mL; nearly a two-fold difference (p<.0001, n=44).  CD44, the receptor for hyaluronic 
acid, was also detected in higher concentrations.  Tenocytes under mechanical strain 
increased their concentration of CD44 by 62.5%, with tenocytes exposed to strain having 
an optical density of 26 · 103 ± 2 · 103 compared with 15 · 103 ± 1 · 103 in controls (p<.05, 
n=6).  The total glycosaminoglycan content of the two groups did not differ significantly; 
strained cells produced 10.2 ± 0.6 µg/mL and controls producing 15.3 ± 3 µg/mL 
(p=0.103, n=44). 
We conclude that mechanical strain in tendon fibroblasts is sufficient to induce 
the production of hyaluronic acid and increase the expression of its receptor, CD44.  The 
results of our study suggest that the beneficial effects on tendon adhesion formation seen 
with both mechanical strain and hyaluronic acid may be related in their mechanism. 
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No subject has created more challenges, interest, or discussion in the field of hand 
surgery than flexor tendon injuries.  Controversies on the proper approach to tendon 
surgery began as early as Galen and Avicenna, and by the 1930s, Bunnell had coined the 
term “No Man’s Land” to describe a portion of the hand in which tendon injuries caused 
particular tribulation.(1) 
 The great difficulty with repairing flexor tendons surgically is the frequent 
creation of fibrotic adhesions between the tendon and surrounding tissues.  These 
accumulations of scar tissue prevent the smooth gliding of the tendons, limiting 
movement and causing debilitating contractures that are the bane of hand surgeons. 
The challenge presented by adhesions has been the focus of many research 
endeavors.  Unfortunately, to date these have met with limited success.  Are they truly a 
“biologic inevitability” as some authors(2) have described them? 
 
Adhesions have long been an obstacle to proper healing after tendon injury or 
repair(3) and have many causes.(4)  They differ in their degree of density, and different 
types of adhesions may be caused by independent regulatory pathways.  This has led to 
attempts by some researchers to develop a standard methodology of measuring adhesion 
biomechanical strength.(5)  Dense adhesions, for example, are characterized not only by 
an increased quantity of collagen than loose adhesions, but also with an increase in the 
ratio of type III to type I collagen and their ratio of cross-linking.(6)  In tendons, 
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fibroblasts from the fibro-osseous sheath have biochemical and cellular differences which 
may enable them to migrate and contribute to their role in adhesion formation.(7) 
Many techniques have been developed to mitigate the development of adhesions 
in tendons including: enveloping the repaired tendons within silicone sheathes(8), fibrin 
glues(9, 10), iontophoresis(11), pulsed electromagnetic fields(12, 13), and thermal 
preconditioning to induce the formation of cytoprotective heat shock proteins(14, 15).  
The results have not translated into successful clinical applications. 
A number of biochemical agents have also been used to thwart the formation of 
adhesions.  Non-steroidal anti-inflammatory agents that inhibit cyclooxygenase (COX) 
and in turn, prostaglandin synthesis, have received some attention.  Indomethacin has 
been shown to be beneficial at reducing adhesions(16-19), and some work shows that 
ibuprofen can also reduce adhesions in both oral(20) and injectable(21) form.  
Conversely, prostaglandins are known to cause or facilitate adhesion formation.(22)  
Corticosteroids(23, 24) and promethazine(25, 26) have also been seen to exert a favorable 
effect.  Some of the benefits to pharmacological anti-inflammatory therapy may be due to 
the decreased edema in tissues.  This is supported by biomechanical animal studies which 
examine the time course of gliding function after injury and reveal a significant 
impediment to gliding within hours of injury, long before adhesion formation can 
occur.(27) 
Intraoperative exposure of repaired tendons to 5-fluorouracil has been shown to 
diminish adhesion formation in rabbit(28, 29) and chicken(30) models, as well as 
reducing the level of TGFβ1 (thought to be involved in the formation of adhesions).(29)  
Later research has shown that this does not decrease the strength of the tendon repair.(31)  
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This may be due to its inhibitory effects on matrix metalloproteinases (particularly mmp2 
and 9).(32)  Aprotinin, another protease inhibitor, has similarly been shown to be 
effective in reducing adhesion formation(33) as has halofuginone, an inhibitor of collagen 
I transcription(34) and Beta-aminopropionitrile (BAPN), an inhibitor of collagen 
maturation.(35)  The effect of these chemicals is to hinder collagen production, a needed 
component for the creation of adhesions.  Collagen itself, when added topically to injured 
tendons, induces the upregulation of collagenase to mediate these effects.(36-38) 
Although some of these have shown promise, the data are usually limited to small 
case series or animal models with clinical trials often yielding disappointing results.  
Despite some indications to the contrary(39, 40), physical barriers to adhesion formation 
such as PTFE have also not proven a useful technique(41-45).  The use of an anti-
adhesive membrane (ADCON-T/N) was evaluated in human flexor tendon repair in a 
prospective double-blind randomized control trial (RCT), and total active motion was 
evaluated at 3, 6, and 12 months after the repair.  Although the length of time taken to 
achieve the final range of motion was shorter in treated patients, the total range of motion 
achieved was not improved.(46)  The failure of ADCON-T/N to prevent adhesions has 
been supported by other researchers.(47) 
As a whole, these studies emphasize that there are a variety of factors which may 
influence the formation of adhesions after tendon surgery.  Along with these biochemical 
signals, mechanical strain also seems to be important for the proper functioning and 
healing of tendons.  The tension-bearing property of tendons is important for the normal 
mechanics of joint motion.  Unfortunately, after surgery tendon motion is limited by pain 
and rupture rates can be high if motion is allowed.  Depending on the particular repair 
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technique and mobilization protocol, the rupture rates of digital flexor tendons range 
from 4%(48) to 46%(49) and 17% for thumbs(50).  On average, the rupture rate 
approaches 10%(48, 50-65), and the rate of “excellent” or “good” results (using 
Strickland’s revised scoring technique, a commonly used tool to evaluate outcomes of 
hand surgery(53)) is often below 75%, although individual results vary considerably. 
Historically, hand immobilization was used to protect flexor tendons after repair.  
This period often lasted three or more weeks, and while effective at minimizing the risk 
of tendon rupture, it had the disadvantage of maximizing the formation of adhesions.  
More recently, a substantial body of literature describing the beneficial role of early hand 
mobilization has been published.  We now know that mobilization is beneficial to the 
smooth gliding of tendons and prevention of adhesions.  And although active 
mobilization can result in rupture(66) or gap formation(67) in animal models, most data 
suggest a positive role.  Overall, animal models using active rehabilitation mobilization 
protocols have been shown to decrease adhesion formation without undue risk of rupture 
when compared to immobilization.(68)  This translates into repairs which are stronger, 
have a more efficient healing process(69) and greater range of motion(70) in the joints 
that they affect. 
The timing of when tendon mobilization is started after surgery is also an 
important factor.  In a study that examined canine flexor tendons after surgical repair, 
immediate mobilization was superior to delayed mobilization in returning range of 
motion (a 50% increase) and dramatically better than immobilized tendons (more than a 
five-fold improvement in angular rotation).(71)  This benefit has been corroborated by 
other studies.(72) 
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There is still some discussion on which protocols maximize the beneficial effects 
of mechanical strain while introducing the least risk of rupture.  It is known that several 
parameters play a role in determining outcome.  The frequency of motion, for example, is 
an important factor, with increased frequency correlated with improved tensile 
strength.(73)  A prospective multi-center RCT was performed to examine the effects of 
daily passive motion and whether increased duration of motion could improve tendon 
gliding after flexor tendon repair.  The authors report that there was a significant benefit 
to increased duration of controlled motion on the range of motion, increasing the angle of 
rotation by 19 degrees.(74) 
This has also translated into clinical research(74-76), and it is now clinically 
accepted practice to apply these protocols to patient care as the most effective method of 
preventing adhesions(4) even in the presence of concurrent digital nerve injuries.(77)  
Previously, it was thought that active mobilization protocols (involving the 
contraction of muscles in continuity with the repaired tendons) would lead to 
unacceptable rupture rates.  Mobilization however, both active and passive, helps tendon 
healing and decreases adhesion formation.  Animal studies have supported a benefit to 
tendon strength and smooth gliding by using controlled passive movement(78) as well as 
active movement.  Prospective trials in humans have shown an advantage in patients who 
have passive(79) and active(57-59) post-operative mobilization.  Although some authors 
report an advantage to active motion(62), at least some data suggest that neither is 
superior to the other.(49)  Active motion can result in higher rupture rates, but an analysis 
of different protocols shows that the risk can be comparable to passive motion if 
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performed judiciously(63) and if the patient avoids imprudent acts which account for half 
of all tendon ruptures.(50) 
Cyclic mechanical loading of tendons to mimic strains encountered during 
mobilization protocols reveals that tenorraphy failure rates may depend on the repair 
technique used.(80)  Indeed, there is an entire body of literature which examines the 
surgical techniques of tendon repair(42) which will not be discussed at length here except 
to say that after tendon injury or repair, there is an increase in the friction of tendon 
gliding which remodels with time.(81)  High friction suture techniques(82) and many 
other factors(83) may centrally contribute to adhesion formation and possibly rupture. 
 
Fibroblasts show a response to mechanical strain in vitro at both a cellular and 
biochemical level.(84)  Tendons in vivo exposed to extracorporeal shock waves after 
injury have been shown to have an increased number of capillaries and decreased 
formation of adhesions, with a correspondingly higher force required to cause 
rupture.(85) 
Cyclical mechanical strain, in particular, seems to be important.  When exposed to 
cyclic mechanical strain, flexor tendons fibroblasts proliferate and align in the direction 
of tension to form a thicker growth layer.(86)  Constant strain,  however, appears to be of 
lesser benefit in healing tendons.(87, 88) 
One question that exists regarding the effect of mechanical strain on healing 
tendons is the degree to which strain actually contributes to the improvements seen with 
active and passive motion rehabilitation protocols.  One theory might argue that only 
motion is important, as the primary mechanism is the mechanical separation of fibrotic 
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bridges which are putative adhesions.  Another view is that the strain is primarily 
important, as the host of growth factors regulated by and affecting strain certainly plays a 
role. 
The question was addressed by a study which examined in vivo chicken flexor 
tendons.  Motion and strain each had an independent roll in generating tensile strength, 
and the combination of the two was greater than either alone.  An increase in collagen 
production, however, was seen only when tendons experienced some type of strain.(89)  
Other studies have shown that the degree of excursion (change in joint angle) is of 
minimal importance in determining the extent of adhesion formation or whether a repair 
will have good range of motion.(90) 
The effect of mechanical strain on the growth factor milieu of tendons is 
paramount.  After tendon injury or repair, a host of growth factors are upregulated.  
Microarray analysis of rat flexor tendons under strain demonstrate an “antifibrotic” 
pattern of gene regulation, with decreased transcription of collagen I and III, FGF, PDGF, 
and IGF1.(91)  IGF has been shown to promote fibroblast growth in culture.(92-94)  In 
contrast, TGFβ1 (which is often associated with increased adhesion formation) was found 
to be upregulated during strain in this study.(91)  The import of this is somewhat unclear. 
The regulation of the TGFβ pathway seems to be particularly important in the 
pathogenesis of fibrosis and formation of adhesions.  It has been shown to be associated 
with adhesion formation, and some studies show that the addition of TGFβ to tenocytes 
in vitro can increase collagen production(95), while neutralizing antibodies to TGFβ can 
decrease collagen production(96).  The role of individual isoforms of TGFβ (TGFB1, 2, 
and 3) are not yet clear.  Most evidence points to TGFβ1 acting to contribute to adhesion 
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formation, and less so for TGFβ2 and 3.  This has been supported by research showing 
decreased adhesion formation in the presence of TGFβ1 blocking antibodies(97) and the 
observation that although TGFβ1 is expressed in healthy tenocytes, the levels rise sharply 
after tendon injury.(98) 
Some research suggests that the site of action of individual growth factors varies 
significantly.  In one study which examined the effect of a tendon injury on growth factor 
regulation at ten days after injury, TGFβ was detected around the repair site and just 
proximal to it, while other factors such as VEGF and PDGF were expressed throughout 
the tendon.  Some growth factors such as EGF, IGF, and bFGF were not seen in 
tenocytes; only in pro-inflammatory cells in the repair site.(99)  This increase in TGFβ 
activation is most pronounced in the tendon sheath and epitenon, peaking within two 
weeks of injury or repair.(100) 
The expression of VEGF in injured tendons suggests that the supply of nutrients 
and oxygen may be an important factor in determining the adhesion forming response of 
healing tendons.  When tendons are examined after repair, progressive changes in the 
microvasculature can be observed.(101)  Revascularization of tendons following injury 
occurs progressively over a 7-21 day window, forming an extrinsic vascular supply.(102)  
In one study, the authors noted a decreasing density and more longitudinal orientation of 
vessels associated with an increasing range of motion after the acute healing phase of the 
first 21 days had passed.(103) 
Other vascular signaling intermediaries have been implicated as well.  Nitric 
oxide synthase (NOS) levels double after an acute tendon injury, and appear to be 
integral to the repair process.  Blocking NOS production creates a persistent, chronic 
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inflammatory response that leads to an increased incidence and severity of 
adhesions.(104)  Lactate can also modulate early wound healing and can stimulate 
collagen production after injury.  Cultured tendon cells exposed to lactate have been 
shown to increase collagen production(105), suggesting that lactate levels may directly 
modulate collagen production during tendon wound healing or repair. 
As newer molecular biology techniques become available, they will advance our 
understanding of the complex growth factor regulation that plays a critical role in the 
biology of adhesion formation and tendon healing.  Adenovirus mediated gene transfer 
appears to be an efficient, dose dependent method of delivering transgenes to flexor 
tendons and at viral concentrations of less than 109, does not appear to engender a 
significant inflammatory response.(106)  Also, antisense oligonucleotides to procollagen 
have been shown effective at reducing collagen production in human tenocytes.(107) 
In sum, many applications for the prevention of adhesions after tendon repair 
have been tried.  Unfortunately, few have met with clinical success.  To understand the 
biological basis of adhesions, a closer look at tendon biology is warranted. 
 
Tendon is specialized connective tissue specifically designed to withstand tension 
and allow the smooth gliding of tissues.  On gross examination, tendons themselves are 
bright white cord or band-like structures that form the structural connections between 
bone and muscle.  Water constitutes approximately 70% of tendon mass(108) with 
collagen I accounting for the majority of the dry mass.  Tendons contain additional 
structural elements, including bone attachment and insertion sites, blood vessels, and a 
dense extracellular matrix.  The primary role of tendons is structural, which is reflected in 
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their decreased metabolic activity.  Oxygen consumption, for example, is 7.5 fold lower 
when compared with skeletal muscles.(109)  This property allows them to function in 
relatively ischemic environments; an important adaptation as tendons are commonly in 
compact anatomical regions with limited tissue perfusion and often under enormous 
tension which would otherwise cause tissue necrosis.  However, the decreased metabolic 
rates also contribute to slower healing after a traumatic insult.(110) 
Although tendons contain some elastin, they are comprised predominantly of 
thick collagen type I fibers and spindle-shaped tenocytes interspersed in a columnar 
fashion among the fibers.  The glycosaminoglycan hyaluronic acid (hyaluronan, 
hyaluronate) is present in small quantities.  External to the collagen fibers is a layer of 
paratenon fibroblasts.  The internal fibroblast may be responsible for the bulk of the 
collagen synthesis, whereas the external cells may provide lubrication for tendon gliding 
during motion.(111) 
At a micro-structural level, tendons are formed by the successive grouping of 
larger and larger bundles of fibers.  At the smallest level, a triple-helix polypeptide chain 
forms “primary bundles” of tropocollagen which are only 15 angstroms in diameter.  
Several small fibers of tropocollagen together form a 35 angstrom microfibril, many of 
which unite to form a subfibril of 100-200 angstroms in width.  Subfibril groups form 
500-5000 angstrom fibrils, and eventually the 50-300 µm fascicles of tendons.(112) 
Each bundle of tendon collagen is covered by an endotenon.  The septa of these 
endotenon form together to constitute an external epitenon that covers the three-
dimensional surface of the tendon.  This is further complemented in the hand by a thin 
adventitia known as the paratenon within a synovial-like fluid environment.(42) 
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This arrangement is coupled by a complex waveform or crimp structure of 
different topographies that forms a dynamic rope-like tendon capable of tremendous 
tensile strength.  Biomechanical analyses, for example, reveal that tendons can withstand 
forces equivalent to thousands of Newtons.(113)  The capacity to produce such a robust, 
complex structure lies in the equally intricate arrangement of cellular subtypes. 
Tendons contain several types of cells.  Tenocytes (or tendon fibroblasts) account 
for 90 to 95% of tendon cells.  Synovial cells, chondrocytes located near osseous 
insertions sites, endothelial cells, smooth muscle cells of arterioles, and immunologic 
cells form the remainder.  Collectively, they are responsible for the formation, 
maintenance and interactions of the extracellular matrix. 
Along with the previously mentioned cellular components, extracellular fluid, and 
collagen and elastin fibers, the extracellular matrix (ECM) contains a fourth component – 
the ground substance.  Ground substance is the portion of the extracellular matrix 
comprised of glycoproteins and proteoglycans – large molecules which are formed by the 
union of a glycosaminoglycan through a trisaccharide link to a protein core.  
Glycosaminoglycans (or GAGs) are synonymous with “mucopolysaccharides” and exist 
independently in the extracellular matrix as the most plentiful heteropolysaccharides in 
the body.  GAGs are formed as long polymers of modified disaccharides and uronic acid.  
Because of their large size (molecular weights in the tens of millions) and predilection for 
absorbing water, glycosaminoglycans often play a structural role in lubrication or 
minimizing mechanical compression. 
 
12 
One glycosaminoglycan of particular interest is hyaluronic acid (HA).  
Hyaluronic acid is a high molecular weight glycosaminoglycan first described in 
1934.(114)  It is formed by the repeating disaccharide N-acetylglucosamine and D-
glucuronate.(115)  Because of its high molecular weight, random coiled structure, and 
ability to attract water, hyaluronic acid is hydrodynamic and forms solutions that have 
high viscosity, elasticity, and propensity for filtration.(114) 
Hyaluronic acid is unique in that it is not sulfated and not covalently bonded to a 
protein, though it does complex with other proteoglycans.  It lubricates tendon tissues and 
is thought to play an important role in the early stages of connective tissue healing and 
scarless fetal wound healing.(116-119)  In an experimental model involving fetal lambs, 
tendons which were injured healed with no subcutaneous scaring, no adhesions, and 
regained a smooth gliding surface with well organized collagen architecture, although 
adult sheep controls experienced significant dense scarring and adhesions.(120) 
Interestingly, it has been shown that acellular amnion membrane (which contains 
elevated concentrations of hyaluronic acid(121)) can prevent the adhesion of tendons 
after repair without compromising tendon healing.(122, 123)  In one study, the combined 
effect of amniotic membranes applied in conjunction with hyaluronic acid was examined.  
Although the researchers reported that this was greater than either amniotic membrane or 
hyaluronic acid alone, it did not reach statistical significance.(124)  Other studies, 
however, have shown in animal models that topical amniotic fluid alone applied during 
tendon repair is sufficient to both decrease adhesion formation and improve the tensile 
strength of the repair.(125) 
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In animal models of osteoarthritis, the addition of hyaluronic acid has been shown 
to provide a lubricating effect, decreasing the friction of tissues.(126)  Even in healthy 
joints, the lubricating effect of hyaluronic acid can be seen.(127) 
It has been suggested that the molecular weight of hyaluronic acid plays an 
important role in determining its effect on adhesion formation.(128)  Some investigators 
have attempted to examine whether the molecular weight affects the mechanical friction 
in joints.  In one study, the researchers injected 1% hyaluronic acid of two different 
molecular weights into the joint spaces of rabbits and determined that molecular weight 
did not play a role in determining the lubricating characteristics.(129)  Unfortunately, the 
molecular weights chosen by the researchers were both similar (one and two million 
Daltons) and relatively low.  As a consequence, they may not have been sufficiently 
different to allow for detection of lubricating or signaling potential.  Moreover, it may not 
be the lubricating role of hyaluronic acid that is central to its effects on tendon healing.   
Hyaluronic acid was previously thought to be an inert molecule that provided 
mechanical compression support in connective tissues.  It is now understood that 
hyaluronan is an active ligand that exerts important regulatory and healing effects 
through hyaluronan-binding proteins, also known as hyaladherins.(114)  These 
interactions make hyaluronic acid an important player in regulating cell mobility, 
adhesion, and proliferation; all important cellular functions in tendons.  Hyaluronic acid 
is also present intracellularly and may be incorporated from extracellular stores(130), or 
produced de novo from within the cell(131) where it is thought to influence cell 
proliferation and motility.(114) 
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 CD44, the primary receptor for hyaluronic acid(132), was first cloned in 
1989.(133)  Antibody mediated activation of the CD44 receptor produces an anti-
inflammatory response(134) and organisms which are engineered to eliminate CD44 gene 
expression (-/-) are unable to properly respond to injury.(114)  In addition, hyaluronic 
acid and its primary receptor, CD44, have been implicated as important cell adhesion 
mediators in the pathogenesis of cancer(135). 
Of the many roles hyaluronic acid is thought to have, the most germane to 
tendons is its role as a structural lubricant and metabolite in the regulation of cell 
proliferation and adhesion formation.  Applied topically during flexor tendon repair in 
animal models, hyaluronic acid has been shown to decrease adhesions at the repair site 
and synovial sheath.  In a study involving the flexor tendons in dogs, for example, 
hyaluronic acid was applied topically to the second and fifth flexor tendons which had 
been transected and repaired.  After five weeks of immobilization, the tendons exposed to 
hyaluronic acid had a significant decrease in both gross and histological adhesions.(136)  
This has also been seen in other studies of rabbits.(137) 
After flexor tendon repair, canine tendons exposed to a hyaluronic acid-
containing solution showed reduced excursion resistance.(138, 139)  By decreasing the 
friction and force on the repaired tendon, increased gliding occurs, which decreases 
adhesion formation(140) and the likelihood of rupture. 
Multiple in vitro and in vivo animal studies have supported a role for hyaluronic 
acid at preventing adhesions.(141, 142)  Collagen contents (adhesions) in peri-tendon 
tissues are decreased, smooth gliding is improved(143), and range of motion is 
greater.(144)  Hyaluronic acid has been shown to increase expression of VEGF and 
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collagen IV when applied to healing tendons after repair, both potential anti-adhesive 
mediators.(140) 
Although some studies have not shown hyaluronic acid to decrease adhesion 
formation(145-147), they are in the minority.  During tendon repair in a rabbit model, 
Seprafilm, a bioresorbable membrane containing hyaluronic acid and carboxymethyl 
cellulose, worked as well as hyaluronic acid gel in the prevention of adhesions and 
improvement of range of motion when compared to controls who received no hyaluronic 
acid.(148)  Benefits are also observed for tenolysis of existing adhesions in a chicken 
model(149) and in dogs.(136)  Other preparations of hyaluronic acid such as Healon and 
viscoelastic gel have been shown to be effective at reducing adhesion formation, even 
when injected into zone II flexor tendon repairs in immobilized primates.(150)  The 
addition of a phospholipid lubricant, dipalmitoyl phosphatidylcholine, has also been 
shown to augment the action of hyaluronic acid, decreasing the friction coefficient and 
formation of adhesions in rabbit flexor tendons.(151)   Exogenously applied hyaluronic 
acid has also been shown to inhibit tendon fibroblast proliferation involved in the 
formation of adhesions in rabbit models.(152) 
A potential role for hyaluronic acid to mitigate adhesion formation is of particular 
interest in hand surgery as adhesions can cause significant functional impairment after 
surgical tendon repair.  Hyaluronic acid, although effective at reducing adhesions 
experimentally, has been disappointing clinically.(153, 154) 
One of the challenges of applying hyaluronic acid as a therapy is its rapid 
absorption in the body.  Hyaluronic acid can be degraded within a matter of hours, and 
within 24 hours, significant dilution may take place.  Higher molecular weight 
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preparations and those that contain a higher initial concentration of hyaluronic acid 
experience a slower decline.(155, 156)  This is further supported by evidence showing 
that hyaluronic acid which has been modified to persist longer has a beneficial effect.  
One group of researchers using a chicken model mixed hyaluronate with 
carboxymethylcellulose and prevented the formation of dense adhesions.(157) 
A rabbit study which reported a beneficial effect from hyaluronic acid, decreasing 
adhesion formation from 95% to 45%, also noted that when adhesions did form in the 
presence of hyaluronic acid, they were less severe.(158)  The authors show in a later 
study that improved function may have been a result of increased viscosity of the 
hyaluronic acid preparation.(159)  Using ex vivo canine tendons as a model, a derivatized 
form of hyaluronic acid, which through chemical modification persists longer than native 
hyaluronate, maintained a lower gliding resistance over many repeated cycles of tendon 
movement than hyaluronic acid or saline.(82) 
Clinically, some researchers have reported beneficial results with hyaluronic 
acid(160), but the vast majority have not.(42)  This disparity between the very promising 
in vitro and animal study findings, and the disappointing clinical observations, is an area 
of great interest.  A better understanding of the biology and regulation of hyaluronic acid 
is needed. 
 It has been shown that removing the tensional loading from tendons either 
experimentally or surgically changes matrix characteristics including increases in total 
glycosaminoglycan content.(111)  Conversely, adding motion to repaired tendons has 
been shown to be beneficial to tendon healing, resulting in fewer adhesions, increased 
strength of repair, and more longitudinal alignment of collagen bundles compared with 
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healing tendons without movement.(54, 71)  How tendon cells perceive changes in 
tensional loading, however, is not well understood.(161) 
While the effects of tensional loading on a variety of protein expression products 
in tendon are known(159-168), the effect of mechanical strain on hyaluronic acid 
production and its receptor, CD44, is uncharacterized in tendons.  Do these two important 
mediators of adhesion formation and tendon healing share a common pathway? 
There is some evidence that suggest they might.  In fibrocartilage tissue, 
mechanical strain has been shown to increase hyaluronic acid production and several of 
its upstream mediators.(162)  If tendon fibroblasts react in a similar way, it would support 
the view that the beneficial effects of mechanical strain, the cornerstone of current 
clinical management of tendon healing and adhesion prevention, are acting at least in part 
through hyaluronic acid, arguably the most promising biochemical player in the 
prevention of adhesions.  With a better understanding of the biochemistry of hyaluronic 
acid and mechanical strain, a more elegant solution to the problem of adhesions may one 




The objective of this study was to isolate rat tendon fibroblasts (tenocytes) and to 
investigate the effect of cyclical mechanical strain on matrix component production, 
specifically hyaluronic acid (HA), its receptor (CD44) and total glycosaminoglycan 
(GAG) production. 
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Materials and Methods 
 
Note on individual performance of research tasks: 
All actual labor for the project including, but not limited to, all procedures, cell 
culture work, animal cell and tissue harvesting, all methods and experiments, generation 
of data, analysis of data, production of reagents, design and selection of assay systems, 
use of assay systems including ELISA, western blots, and colormetric dye-binding 
assays, preparation of cell lysates, and antibody utilization were performed personally by 
Richard Crockett.  In addition, Richard Crockett was personally responsible for the use, 
configuration, and repair of the FlexCell unit, as well as the selection, evaluation, 
procurement and price negotiation of all required reagents and materials, budget 
management, and project timeline planning. 
 
Certain elements of the research relied on personnel other than Richard Crockett: 
Training of Richard Crockett in the use of western blot technique and photographic film 
use was performed by Dr. Michael Centrella. 
 
Training of Richard Crockett in surgical dissection techniques for rat tail tendons was 
performed by Dr. J. Grant Thomson. 
 
Training of Richard Crockett in the culture of tenocytes was performed by Dr. Martijn 
van Griensven in Hannover, Germany. 
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Certain elements of the conceptual and pragmatic research plan relied heavily on the 
creative input of personnel other than Richard Crockett: 
Development of laboratory strategies to efficiently obtain data involved discussions with 
Dr. Thomas McCarthy and Dr. Michael Centrella. 
 
Development of strategies involved in design of the strain protocol and overall research 
goals involved discussions with Dr. J. Grant Thomson. 
 
Methods Summary: 
The research involved several stages, which are explained in detail below.  
Briefly, rat tail tendons were surgically dissected and the tendon fibroblasts were 
removed and cultured.  After two passages, these cells were transferred to flexible 
membrane culture dishes and assigned to an experimental or control group.  The 
experimental group was exposed to a cyclical mechanical strain, while the control (or 
static) group was not.  The cells were then analyzed for changes in three targets of 
interest: hyaluronic acid, the receptor for hyaluronic acid (CD44), and total 
glycosaminoglycan content. 
 
Harvest of Tendon Cells:  
The tendon fascicles were harvested from 12 adult Sprague-Dawley rats (Charles 
River Laboratory; Wilmington, MA).  All animal care complied with the IACUC and 
NIH protocols for the care and use of laboratory animals.  The rats were sacrificed with 
an overdose of isofluorane and cervical dislocation.  The tail and hindquarters were 
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immersed in 95% ethanol then thoroughly rinsed in sterile saline.  After transecting the 
tail, the skin was removed and discarded.  The transected tail was transferred to a 150mm 
Petri dish (Corning; Corning, NY) and using sterile technique, tendon fascicles from 
dorsal, ventral, and lateral tendon groups in the anterior two-thirds of the tail were 
removed.  After the paratenon was removed, the tissue was divided into 3-5mm2 samples 
and placed in 60mm Petri dishes (Corning).  For each piece of tissue, a small area of the 
dish was abraded with a number 11 scalpel blade.   The tissue was allowed to partially air 
dry for several minutes in a sterile laminar flow hood in order to increase adherence.  3-
5mL of culture medium was then slowly added.  The culture medium consisted of 
Dulbecco’s modified Eagle’s Medium (DMEM) with Ham’s F-12 (1:1) and L-glutamine 
(Gibco; Grand Island, NY) supplemented with 10% fetal calf serum (Gibco).  
Penicillin/streptomycin species (100 U/mL) was also added to the medium. 
 
Culture of Tendon Cells: 
In a 37°C non-moving 5% CO2 incubator, the tissue was left undisturbed for 2-3 
days.  Tenocytes migrated from the clumps of tendon tissue.  After tenocyte growth 
reached 75-80% confluence, the tendon tissue was removed.  The medium was removed 
by suction and the dish was bathed in 1-2mL 0.25% trypsin with EDTA (Gibco) at 37°C 
for 10 minutes.  The trypsonized cells were placed in a 15 mL Falcon tube to which 
culture medium was added.  The cells were then collected by sedimentation, resuspended 
in culture medium and plated in the culture medium on 25cm2 filter-top culture flasks 
(Nunc; Roskilde, Denmark).  The cells were observed daily under an inverted phase-
contrast microscope (Olympus; Melville, NY).  Medium was changed every other day. 
21 
When the cells had reached 75-80% confluence, the medium was discarded and 
the cells were freed with trypsin as described above.  Cells were then split and plated 
onto three 80cm2 filter-top culture flasks.  When these cells had reached 75-80% 
confluence, they were plated on Bioflex® plates (Flexcell International; McKeesport, 
PA); culture dishes containing a flexible silastic membrane bottom.  These culture dishes 
contained 6 wells, with each well bottom consisting of a flexible membrane which had 
been previously coated with fibronectin to facilitate fibroblast cell adhesion. 
Cultured cells were plated on the same type of Bioflex plate, irrespective of group 
(strained or static).  Only after the cells had been cultured and were ready for the strain 
protocol were the culture dishes assigned in a random fashion to either the strained or 
static group.  This was done to prevent any selection bias based on cell line.  Cell density 
was determined using a hemocytometer and cells were plated at approximately 10,000 
cells/57.75cm² Bioflex plate. 
 
Strain Protocol: 
The Flexercell® Strain Unit applies cyclic strain to cells cultured to confluence on 
flexible membranes (Flexcell International).  The unit exerts a vacuum pressure on a 
silastic membrane at the bottom of each 6-well plate that has been pre-coated with 
fibronectin.  The unit fits inside a standard CO2 incubator and the duration, frequency, 
and magnitude of stress can be adjusted.  A 5% change in the size of the membrane 
approximates a 2% change in the length of cells on the membranes; similar to the amount 
of elongation collagen experiences under physiologic conditions.(161)  To select an 
appropriate strain regimen, we attempted to mimic active rehabilitation protocols, which 
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involve periods of repeated strain followed by comparatively longer periods of rest and 
recovery.  Previous studies have shown that the magnitude and duration of strain(163), as 
well as the length of the rest between stain periods are important parameters(164), but the 
frequency of strain is less important.(163)  Accordingly, cells were strained at 1 Hz for 
five minutes and allowed to rest for 55 minutes.  This was repeated over the course of 8 
hours, after which the cells were allowed to rest for 24 hours before collection so that any 
translational or post-translational events would have sufficient time to occur.  Both the 
medium and cells were collected for analysis. 
Cultured tenocytes were divided into two groups – an experimental group, which 
was exposed to the mechanical strain regimen, and a control or static group which was 
not exposed to any strain.  Both groups were extracted and cultured in identical 
conditions at the same time and each replicate was derived from an independent cell 
lineage.  During the strain regimen, strain cells which had been cultured on the Bioflex 6-
well plates were placed in the strain unit.  Static cells were placed in the same incubator 
at the same time as the strained cells but were not exposed to any strain. 
 
Hyaluronic acid content 
Hyaluronic acid concentration was measured using an enzyme linked protein 
assay (Corgenix; Westminster, CO).  Using a capture molecule called Hyaluronic Acid 
Binding Protein (HABP) which is bound to horseradish peroxidase (HRP), the assay is 
visualized with a chromogenic substrate and measured in optical density with a 
spectrophotometer.  Because hyaluronic acid is primarily secreted into the extracellular 
23 
tissue matrix, we compared the concentration in the media from strained cells to that 
found in the media of static cells. 
 
CD44 receptor expression 
Immunolabelling for CD44 was performed using a polyclonal rabbit antibody to 
CD44 (Santa Cruz Biotechnology; Santa Cruz, CA).  After the medium had been 
removed from the Bioflex plates, the cellular layer was collected and homogenized using 
a sonicator.  The homogenate was normalized for total protein content and separated by 
charge to mass ratio using SDS polyacrylamide gel electrophoresis.  The proteins were 
electroblotted onto PolyScreen polyvinylidene difluoride transfer membrane 
(PerkinElmer Life Sciences, Wellesley, MA).  The western blot was then probed using 
primary antibody (as described above) in TBST with milk at 20°C overnight.  The 
secondary antibody was goat, anti-rabbit conjugated to HRP (Santa Cruz) and 
immunocomplex formation was visualized with chemiluminescence and exposure to 
photographic film. 
 
Total glycosaminoglycan (GAG) content 
To measure the amount of glycosaminoglycan (GAG) present in the medium, a 
colormetric assay was used which involves the binding of a dye (dimethyl-methylene 
blue) to GAGs (Biocolor Assays; Newtownabbey, Northern Ireland).  A dye solution 
which includes DMB dye and an inorganic solvent are added to the sample. The dye is in 
excess and binds with GAGs, precipitating out of solution.  After centrifugation, the 
resulting pellet contains the dye-GAG complex, and the supernatant contains unbound 
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DMB dye and solvent.  Resuspension of the pellet in propanol to disassociate the dye 






An unpaired two-tailed Student’s t-test was used to compare strained and static 
groups.  A value of p < 0.05 was considered significant.  Western blots were optically 




 During the harvest of the tendon fibroblasts, 12 animals were dissected and the 
tendons were removed.  Two additional animals were used solely for practice of the 
tissue harvest and culture and were not part of the experiment.  Although it was initially 
challenging to separate the tendon from the surrounding tissue (including the paratenon), 
once the technical elements were refined the process became straightforward.  Each 
animal yielded a sufficient quantity of tendon tissue such that each control and 
experimental cell line consisted of tenocytes with a distinct cell lineage from the others.  
These were cultured in parallel, under identical conditions.  One culture developed a 
fungal infection before assignment to either the experimental or control group and was 
discarded. 
 
Hyaluronic Acid Content 
 Since hyaluronic acid is produced by fibroblasts and found primarily in the 
extracellular environment, the medium in which the cells were cultured was analyzed 
quantitatively for hyaluronic acid content.  The removed media were normalized for total 
protein content before analysis.  Using an ELISA assay, 44 medium samples (22 
experimental, 22 control) were analyzed.  The medium of tenocytes which had 
experienced cyclical mechanical strain had a greater concentration of hyaluronic acid 
(1528 ± 58 ng/mL (mean ± SEM)) compared with the medium of tenocytes that had not 
been subject to strain (730 ± 27 ng/mL).  This constitutes nearly a two fold increase in 





    Assay   
Group Hyaluronic Acid CD44 Receptor Glycosaminoglycans
 ng/mL O.D. µg/mL 
Strained 1528 +/- 58 25525 +/- 2461 10.2 +/- 0.6 
Static 793 +/- 27 15454 +/- 1443 15.3 +/- 3.0 
    





CD44 receptor expression 
 Hyaluronic acid as a signaling molecule acts primarily through its receptor, 
CD44.  To assess whether there were changes in the population of the CD44 receptor, the 
cell membranes of the tenocytes were analyzed for the presence of CD44.  To allow for 
the transcription and membrane translocation of the receptors, a delay of 24 hours 
between the end of the mechanical strain regimen and collection was instituted.  Using a 
western blot analysis, 6 (3 experimental, 3 control) cellular homogenate samples from 
independent cell lineages were analyzed for expression of CD44.  (See figure 1).  
Tenocytes under mechanical strain increased their concentration of CD44 by 62.5%, with 
tenocytes exposed to strain having an optical density of 26 · 103 ± 2 · 103 compared with 







Figure 1  
 
 







Total glycosaminoglycan content 
 The total amount of glycosaminoglycan produced by tenocytes in both the 
strained and static groups was measured to examine what effect mechanical strain had on 
the production of these structural polysaccharides.  Using a commercially available 
colormetric dye-binding assay, 44 medium samples (22 experimental, 22 control) were 
analyzed for content of glycosaminoglycans.  No significant differences were detected in 
glycosaminoglycan content between the media of tenocytes which had been cyclically 
strained versus cells which were not, with strained cells producing 10.2 ± 0.6 µg/mL and 




Proper tendon healing after repair requires a balance between appropriate fibrous 
connective tissue formation to provide tensile strength and the formation of excessive 
scar tissue, fibrosis, which impedes the smooth gliding of structures and leads to 
adhesions and impairment of function.  Mechanical strain has been shown important in 
this collagen production and the linear organization of collagen fibrils(54).  Its role both 
in animal models and clinical settings is widely accepted.  The active rehabilitation 
protocols used for hand surgery patients currently employed are designed to tread 
between these two extremes: too little activity or strain can result in the formation of 
adhesions, while excessive strain can result in rupture at the site of tenorraphy. 
Understanding the effects of mechanical strain on tendon fibroblasts is important 
in finding adjunct medical therapies which would mitigate fibrosis and adhesion 
formation without weakening tendon repair.  One such candidate is hyaluronic acid—a 
high molecular weight polysaccharide found throughout the body that provides 
lubrication in joints and the smooth gliding of tendons.  More recently, research has 
shown that in addition to its structural and lubricating role, hyaluronic acid as an 
important signaling molecule for cell motility, adhesion, and proliferation. 
Hyaluronic acid has been shown to be beneficial in preventing or decreasing 
adhesions in animal models including chicken(142, 144, 149), rabbit(137, 143, 148, 152, 
158), canine(136), horse(141), and primate.(150)  Unfortunately, this success in animal 
models has not translated into clinical applications.(42, 153, 154)  This disappointing gap 
suggests that a closer look at hyaluronic acid may be warranted. 
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Our study examined whether mechanical stress might directly influence 
hyaluronic acid regulation.  The model we chose was one in which rat tail tenocytes were 
exposed to cyclic strain in vitro.  One question that this raises is whether this is a valid 
model for examining the effects on tendon fibroblasts. 
Dissociated cells and tendon explants do appear to be good models for examining 
the effects of mechanical strain on tenocytes.  Dissociated tenocytes bond well to 
fibronectin as demonstrated in biomaterial studies which examine adhesion strength.(165) 
Tendon explants and dissociated fibroblasts grown in culture retain their ability to 
respond to mechanical stress.(111, 161, 166-171)  Moreover, the effects seen correlate 
well with the effects of mechanical strain seen in vivo.(172-176) 
Part of the difficulty in teasing apart the role of hyaluronic acid is that it seems to 
behave differently based on its molecular weight, concentration, and the presence of other 
growth factors.  In fact, despite evidence that hyaluronic acid is a key molecule in tissue 
healing, cell migration, and adhesion formation, we know little about how it is regulated. 
 Probably the most important regulator of hyaluronic acid is hyaluronic acid 
synthase (HAS), particularly the second isoform, Has2(177, 178).  In a study that 
examined wound healing with cell lines that expressed sense and anti-sense Has2, the 
increased cell migration and faster healing seen with sense Has2 was absent in cells 
expressing anti-sense Has2.  The anti-sense Has2 cells were also associated with an 
increase in adhesive plaques.  Exogenous hyaluronate was not able to overcome the 
deficiency, suggesting that activation of Has2, more than the quantity of hyaluronic acid, 
is the key determiner of how adhesions are formed and regulated by the hyaluronan 
pathway.(179) 
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This raises the question: if hyaluronic acid is beneficial to tendon healing, would 
inhibiting the enzymes which degrade it (hyaluronidases) be beneficial as well?  The 
answer in tendons has not been explored.  In intra-peritoneal adhesions however, where 
some data suggest that hyaluronic acid is helpful in reducing the adhesion 
formation(180),  the effect has been examined(181, 182) and some researchers have seen 
a benefit.(183) 
In sum, it seems that hyaluronic acid has more than one role as a signaling 
molecule.  At a molecular level, hyaluronidase can suppress the rapid interactions that 
occur early in cell adhesion formation.  When a small amount of hyaluronic acid exists, it 
can serve to facilitate cell-matrix adhesion, whereas excess hyaluronic acid strongly 
inhibits cell adhesion.(184)  Thus, it seems that hyaluronic acid may help to allow cells to 
interact, move and bind together, while at the same time, larger amounts may help 
prevent adhesion formation. 
  This study showed a significant increase in both hyaluronic acid and its receptor 
(CD44) when tenocytes were exposed to cyclical mechanical strain in vitro.  Our study is 
the first to examine the effects of mechanical strain on the regulation of hyaluronic acid 
in tendons.  It is clear from our study that mechanical strain, which is an integral part of 
the repair process, plays a role in the regulation of tendon fibroblast hyaluronic acid 
production.  How that translates into adhesion formation still needs to be explored, 
however. 
When we examined the total glycosaminoglycan content, it was not found to be 
significantly altered by mechanical strain, though other investigators have shown 
previously that many stimuli including in vitro culture alone can alter total and sulphated 
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GAG content(111).  The increase in hyaluronic acid, but not total glycosaminoglycan 
content, may reflect the preferential effect of mechanical strain on the hyaluronan 
pathway.  Another possibility is that we did not observe any change in 
glycosaminoglycan content in response to mechanical strain because of limitations of the 
assay, which performed poorly even during calibration of standards.  Additionally, the 
assay we performed examined the presence of glycosaminoglycans in the supernatant.  
The predominance of glycosaminoglycans may have been intimately associated with the 
cell membranes and not readily present in the supernatant. 
Hyaluronic acid is a promising target for mitigating adhesion formation.  
Unfortunately, the clinical applications to date related to post-operative tendon repair 
have been disappointing(153, 154).  In addition to the complexities of its regulation and 
mechanisms of action, use of hyaluronic acid has been challenged by its rapid catabolism 
and dilution in the body. 
Newer, derivatized formulations of HA show longer persistence and less friction 
in tendons after repair(185) and have been used for a variety of purposes(186) from 
coating metallic artificial joints(187) to forming biologically compatible hydrogels.(188)  
Other researchers have created cross-linked hyaluronic acid films which contain DNA 
encoding hyaluronan synthase 2 (HAS2).  The goal of these biofilms is to provide a 
physical barrier while at the same time delivering hyaluronan and upregulating HAS.  
The films are subject to the same catabolism by hyaluronidases as native hyaluronic acid, 
and as such subject to breakdown, but cross-linked hyaluronic acid-collagen sheets which 
are resistant to hyaluronidase over several weeks have been developed.(189)  Hopefully, 
these promising discoveries will translate into viable clinical applications. 
32 
The future role of hyaluronic acid as an adjunct medical therapy to prevent the 
formation of adhesions after tendon surgery is unclear.  The current challenges in 
understanding how hyaluronic acid fits into the larger process of wound healing are 
interesting avenues of research, however, and as the details of its regulation and 
mechanisms of action are revealed, perhaps a clearer path to preventing tendon adhesions 
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